Pharmaceuticals Africa

Africa PTSD Treatment Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Africa PTSD Treatment Market Industry Trends and Forecast to 2034: Segmented by (Treatment, Population, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Africa · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $23.4 Mn Placeholder estimate
Estimate 2025 $25.1 Mn 1.5% of the global market
Projected 2034 $47.8 Mn 90.1% Adds $22.7 Mn over 9 forecast years
CAGR 2025–2034 7.4% Faster than 23% of 180 Pharmaceuticals markets here
Key players 5
  • Africa is 1.49% of the global market.
  • Among regions, the largest is North America at $783.1 Mn.
  • Fastest growing: Africa (this report) at 7.4% a year.
  • Africa ranks 6th of 6 by size among regions.

Market size projection

Africa

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$22.7 Mn total, 2026–2034

Year-by-year market size, 2024–2034
PTSD Treatment Market market size by year, Africa
YearMarket sizeChange that yearSince 2025
2024 (estimate) $23.4 Mn — —
2025 (base) $25.1 Mn +$1.7 Mn —
2026 (forecast) $27.0 Mn +$1.9 Mn +7.4%
2027 (forecast) $29.0 Mn +$2.0 Mn +15.3%
2028 (forecast) $31.2 Mn +$2.1 Mn +23.9%
2029 (forecast) $33.5 Mn +$2.3 Mn +33.1%
2030 (forecast) $35.9 Mn +$2.5 Mn +42.9%
2031 (forecast) $38.6 Mn +$2.7 Mn +53.5%
2032 (forecast) $41.4 Mn +$2.9 Mn +64.8%
2033 (forecast) $44.5 Mn +$3.1 Mn +77%
2034 (forecast) $47.8 Mn +$3.3 Mn +90.1%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Africa PTSD Treatment Market Analysis at a glance
Market size, 2025$25.1 Mn placeholder estimate
Forecast, 2034$47.8 Mn placeholder estimate
Growth (CAGR), 2025–20347.4% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
Also calledPost-Traumatic Stress Disorder Treatment
SegmentsTreatment, population and end user (see all)
Key playersPfizer Inc., Viatris, Lykos Therapeutics, Otsuka Pharmaceutical Co., Ltd., Tonix Pharmaceuticals (see all)
Regulator in AfricaAMASource: African Union, African Medicines Agency treaty. Checked 14 Nov 2026.
Active clinical trials4 in AfricaSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Africa. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Africa PTSD Treatment Market Analysis Executive Summary

PTSD treatment helps people recover from trauma using therapies, medicines and new approaches such as MDMA-assisted therapy.

Key segments of the PTSD Treatment market include treatment (Psychotherapy, SSRIs and SNRIs and Psychedelic-Assisted Therapy) and population (Veterans and Military and Civilians).

Bar chart: Africa PTSD Treatment market size, 2024–2034, placeholder estimates. $23.4 Mn in 2024, $25.1 Mn in 2025 and $47.8 Mn in 2034, 7.4% CAGR.
Africa PTSD Treatment market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Africa PTSD Treatment Market Dynamics

Market Growth Drivers

More people seeking help for mental health, less stigma, better screening and new treatments with faster effects are driving the PTSD Treatment market. Governments and employers are investing more in mental health care.

Opportunity

Digital tools, new drug classes and care built into primary care and workplaces give the PTSD Treatment market strong room to grow worldwide.

Market Restraints

Shortages of mental health professionals, limited insurance coverage, side effects and the need for long-term treatment hold back the PTSD Treatment market.

Competitive Landscape for PTSD Treatment Market in Africa

The PTSD Treatment market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for PTSD Treatment Market in Africa

PTSD Treatment in Africa: rules, payment and research

The African Medicines Agency (AMA), set up by an African Union treaty in force since November 2021, aims to bring the work of national regulators together.⁠[1] In some of the countries we cover here, medicines are approved by EDA (Egypt)⁠[2], PPB (Kenya)⁠[3] and SAHPRA (South Africa)⁠[4]. How care is paid for in some of these countries: universal health insurance (Egypt)⁠[5], the SHA (Kenya)⁠[6] and planned National Health Insurance (South Africa)⁠[7]. ClinicalTrials.gov lists 4 studies on PTSD Treatment that are recruiting, active or about to start in Africa.⁠[8]

[1] African Union, African Medicines Agency treaty. Checked 14 Nov 2026.

[2] Egyptian Drug Authority. Checked 14 Nov 2026.

[3] Pharmacy and Poisons Board. Checked 14 Nov 2026.

[4] South African Health Products Regulatory Authority. Checked 14 Nov 2026.

[5] Universal Health Insurance Authority. Checked 14 Nov 2026.

[6] Social Health Authority. Checked 14 Nov 2026.

[7] National Department of Health. Checked 14 Nov 2026.

[8] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Africa. Retrieved 12 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for PTSD Treatment. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Africa.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in PTSD Treatment right now, from free public sources.

Clinical trials

4 active trials in Egypt, South Africa, Kenya, Nigeria, Ethiopia, DR Congo, Uganda, Tanzania, Niger, Mozambique, Sudan, Malawi, Zambia, Mali, Burkina Faso, Ghana and Morocco

Recruiting, about to start, or running now. Counted across the 17 countries we report on in Africa.

Top trial sponsors (worldwide)

  1. Transcend Therapeutics 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Patients

Suicide rate, per 100,000 people (WHO)
CountryValueYear
Burkina Faso7.02023
DR Congo7.62023
Egypt0.72023
Ethiopia5.72023
Ghana7.92023
Kenya7.92023
Malawi9.22023
Mali4.22023
Morocco3.22023
Mozambique6.12023
Niger4.92023
Nigeria2.72023
South Africa15.32023
Sudan3.02023
Tanzania5.82023
Uganda5.92023
Zambia8.92023
Compare every country on the Public Health Dashboard

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

PTSD Treatment in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the PTSD Treatment market in Africa?
Placeholder estimate: about $25.1 Mn in 2025, rising to about $47.8 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the PTSD Treatment market in Africa growing?
Placeholder estimate: about 7.4% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the PTSD Treatment market report cover?
The report splits the market by treatment (Psychotherapy, SSRIs and SNRIs, Psychedelic-Assisted Therapy, Digital Therapy), population (Veterans and Military, Civilians) and end user (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies).
Who are the key players in the PTSD Treatment market?
Key players include Pfizer Inc., Viatris, Lykos Therapeutics, Otsuka Pharmaceutical Co., Ltd. and Tonix Pharmaceuticals.
What is driving the PTSD Treatment market?
More people seeking help for mental health, less stigma, better screening and new treatments with faster effects are driving the PTSD Treatment market. Governments and employers are investing more in mental health care.
Who regulates PTSD Treatment in Africa?
The African Medicines Agency (AMA), set up by an African Union treaty in force since November 2021, aims to bring the work of national regulators together. Source: African Union, African Medicines Agency treaty. Checked 14 Nov 2026.
How many clinical trials on PTSD Treatment are running in Africa?
4 studies are recruiting, active or about to start in Africa, counted across the 17 countries we report on there, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Africa. Retrieved 12 Nov 2026.
How much research is published on PTSD Treatment?
PubMed lists 660 papers on PTSD Treatment added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Pharmaceuticals reports in Africa

See all

Related on mental health

See the topic